+ Reply to Thread
Results 1 to 4 of 4
  1. #1
    Member
    Join Date
    Oct 2013
    Posts
    93

    Post Restorgenex - new directors

    Restorgenex / Histogen
    Looks like they are going ahead with the reverse merger as planned:

    http://www.sec.gov/Archives/edgar/da..._8k-110113.htm

    Quote from SEC filing:

    'Effective November 1, 2013, Sol J. Barer, Ph.D. and Isaac Blech were elected by the Company’s board of directors (the “Board”) as new directors. Dr. Barer was also named Chairman of the Board and Mr. Blech was named Vice Chairman of the Board. Dr. Barer and Mr. Blech have also been appointed to serve on the Company’s Audit and Compensation Committees. Their compensation as board members has not yet been determined. Also effective November 1, 2013, Jerold Rubinstein resigned as Chairman of the Board but remains as Chairman of the Board’s Audit Committee and Chief Executive Officer.'

  2. #2
    Junior Member
    Join Date
    Dec 2013
    Posts
    18

    Default

    and what does it mean that all
    it tells us no more about the testing phases

  3. #3
    Junior Member
    Join Date
    Dec 2013
    Posts
    18

    Default

    histogen restrogenex fusion and is it effective?

  4. #4
    Member
    Join Date
    Oct 2013
    Posts
    93

    Default

    Well I can say for certain now, Histogen say they have ceased pursuit of the merger agreement with Restorgenex.
    Instead, they are now moving forward with Series B financing.

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts

» IAHRS

hair transplant surgeons

» The Bald Truth